Stage Iva Prostate Cancer Ajcc V8

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-09-28
Clinical Trial Update: Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer [Phase 2]
Phase 2 trial investigating erdafitinib combined with abiraterone acetate or enzalutamide in double negative prostate cancer; study terminat…